E17D (p.Glu17Asp) variant of RLBP1 (Retinaldehyde-binding protein 1)

E17D (p.Glu17Asp) in RLBP1 (Retinaldehyde-binding protein 1) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.16 / 1. The record also includes population frequency data and structural context.

E17D (p.Glu17Asp) variant details